Clinical Trials
Enrolling Trials
111-120 of 169
CIRB, Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Lung
Adult
Abstract 03292023 - OpID Velos Only Project Create 103292023 - OpID Velos Only Project Create 103292023 - OpID Velos Only Project Create 1
MMC - Eau Claire Cancer Center
2200 Craig Road
Eau Claire, WI 54701
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
MMC - Minocqua
9576 Highway 70
MINOCQUA, WI 54548
MMC - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
MMC - River Region at Stevens Point
4100 State Highway 66
Stevens Point, WI 54482
MMC - Weston
3400 Ministry Parkway
WESTON, WI 54476
CIRB, A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Wernberg, Jessica A
Breast
Adult
haoidjfioadjfa
MMC - Eau Claire Cancer Center
2200 Craig Road
Eau Claire, WI 54701
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
MMC - Minocqua
9576 Highway 70
MINOCQUA, WI 54548
MMC - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
MMC - River Region at Stevens Point
4100 State Highway 66
Stevens Point, WI 54482
zzzDiagnostic & Treatment Center
3401 CRANBERRY BLVD
WESTON, WI 54476
zzzMarshfield Medical Center
611 Saint Joseph Ave
Marshfield, WI 54449
Optimizing Medication management for Mothers with Depression (OPTI-MOM)
Miscellaneous
Adult
The overarching goal of this NICHD-funded U54 Obstetric-Fetal Pharmacology Research Center study is to develop evidence to construct guidelines for the optimal use of SSRI antidepressants in pregnant women. The progressive changes in plasma SSRI and metabolite concentrations across pregnancy and after birth will be determined in an observational study.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Assessment of outpatient opioid use after total knee arthroplasty
Miscellaneous
Adult
The goal of this study is to determine the average amount of oral opioid analgesics consumed during outpatient recovery following a total knee arthroplasty (TKA) in both opioid-naïve and pre-operative chronic opioid users.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
ICH-A Phase 1/2, Open-Label, Randomized Parallel Arm, Intra-patient Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of CNSA-001 (Sepiapterin) in Primary Tetrahydrobiopterin Deficient Patients with Hyperphenylalaninemia
Phase 1 Studies
Adult
To assess the safety and tolerability of 4 dose levels of CNSA-001 in primary tetrahydropterin deficiency (PBD) patients with 6-pyruvoyl-tetrahydropterin synthase (PTPS) or recessive guanosine triphosphate cyclohydrolase 1 (GTP-CH) deficiency
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Objective Assessment of physical Activity and Sleep Behavior in Patients with Bardet-Biedl Syndrome. Sub-Study of CRIBBS
A cardinal feature of the rare disease Bardet-Biedl syndrome (BBS) is obesity. The purpose of this study is to examine physical activity and sleep behavior in individuals with BBS using a wrist-worn accelerometric device. The device will be worn for two week periods on repeated occasions to obtain information on activity and sleep behavior in individuals with BBS. Activity and sleep data will be correlated with health information currently collected in CRIBBS. Information gathered in this research is anticipated to promote understanding of energy metabolism and inform design of lifestyle interventions to treat obesity in the BBS population.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Prescreen Failure (BREAST) Data Repository Project
Data Repository - IRB Expedited Approval (SP# WEI30611). For reporting purposes only Prescreen Failure (Disease Team Site Specific) in VELOS was created. Each disease site is NOT a separate IRB approved study, all data is applicable under SP# WEI30611.
MC - Chippewa Falls Center
2655 CTY HWY I
CHIPPEWA FALLS, WI 54729
MC - Wausau Center
2727 PLAZA DRIVE
WAUSAU, WI 54401
MC - Wisconsin Rapids Center
220 24TH ST SOUTH
WISCONSIN RAPIDS, WI 54494
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
MMC - Minocqua
9576 Highway 70
MINOCQUA, WI 54548
MMC - Rice Lake
1700 W STOUT ST
RICE LAKE, WI 54868
MMC - Weston
3400 Ministry Parkway
WESTON, WI 54476
zzzDiagnostic & Treatment Center
3401 CRANBERRY BLVD
WESTON, WI 54476
zzzMarshfield Clinic At James Beck Cancer Center
2251 NORTH SHORE DR
RHINELANDER, WI 54501
zzzMarshfield Clinic Cancer Care At St Michaels
900 ILLINOIS AVE
STEVENS POINT, WI 54481
zzzMarshfield Medical Center
611 Saint Joseph Ave
Marshfield, WI 54449
zzzMfld Clinic Cancer Care at Sacred Heart Hospita
900 W CLAIREMONT AVE
EAU CLAIRE, WI 54701
zzzSacred Heart Hospital (Eau Claire)
900 W Clairemont Ave
Eau Claire, WI 54701
zzzSt. Clare's (Weston)
3400 Ministry Parkway
Weston, WI 54476
zzzSt. Mary's
2251 North Shore Drive
Rhinelander, WI 54501
zzzSt. Michaels Hospital
900 Illinois Ave
Stevens Point, WI 54481
Prescreen Failure (Cancer Control Studies) Data Repository Project
Data Repository - IRB Expedited Approval (SP# WEI30611). For reporting purposes only Prescreen Failure (Disease Team/Site Specific) in VELOS was created. Each disease site is NOT a separate IRB approved study, all data is applicable under SP# WEI30611.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Prescreen Failure (CCDR) Data Repository Project
Data Repository - IRB Expedited Approval (SP# WEI30611). For reporting purposes only Prescreen Failure (Disease Team/Site Specific) in VELOS was created. Each disease site is NOT a separate IRB approved study, all data is applicable under SP# WEI30611.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Prescreen Failure (GU) Data Repository Project
Data Repository - IRB Expedited Approval (SP# WEI30611). For reporting purposes only Prescreen Failure (Disease Team Site Specific) in VELOS was created. Each disease site is NOT a separate IRB approved study, all data is applicable under SP# WEI30611.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449